Building Value Early: Differentiation and Patient-Centric Strategy in the Pipeline

In this three-part series, Michael Parisi, Lumanity’s Chief Client Officer, will explore Lumanity’s Value Inflection Point framework with leaders from across biopharma. Each session will dive into the real-world insights from executives who have navigated these pivotal moments – from early asset strategy to launch execution and post-market optimization.

In part one, we’ll explore how early-stage decisions have an outsized impact on long-term success.

Joe Guidi, VP, Medical Early Differentiation and Pipeline at Bristol Myers Squibb has created early pipeline strategies that align scientific ambition with market needs and patient priorities, years before launch.

This webinar will explore how engaging early at the first Value Inflection Point to define a differentiated value proposition, anticipate market and regulatory shifts, and embed patient insights can set the stage for sustained success.

Tuesday, December 9, 2025
11:30am–12:00pm EST